Waseem Barham
Interventional Cardiology · South Bend, INNPI 1053540203
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Edwards Lifesciences at 27.3% of the total. Reporting peaked in 2023 at $5,951 and has fallen 63.2% since, to $2,191 in 2025.
Across 229 payments — averaging $58.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$4K
- Boston Scientific$3K
- Abbott$1K
- Abiomed$981
- Novartis$796
- Philips North America LLC$753
- plus $3K from 18 others
What the payments were for
- Travel & lodging$6,89351%
- Food & beverage$6,44748%
- Education$1391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 43 | $3,677 |
| Boston Scientific | 30 | $3,479 |
| Abbott | 9 | $1,095 |
| Abiomed | 8 | $981 |
| Novartis | 36 | $796 |
| Philips North America LLC | 5 | $753 |
| Shockwave Medical, Inc | 12 | $524 |
| Medtronic(2 entities) | 6 | $415 |
| E.r. Squibb & Sons, L.L.C. | 12 | $218 |
| Johnson & Johnson | 14 | $213 |
| Amgen | 9 | $186 |
| Actelion Pharmaceuticals US, Inc. | 6 | $155 |
| Bard Peripheral Vascular, Inc. | 1 | $137 |
| Cardiovascular Systems Inc. | 1 | $120 |
| AstraZeneca | 9 | $120 |
| Pfizer | 6 | $106 |
| Sanofi-aventis U.S. LLC | 2 | $102 |
| Boehringer Ingelheim | 5 | $93 |
| Penumbra, Inc. | 1 | $92 |
| Bayer | 4 | $61 |
| Lexicon Pharmaceuticals, Inc. | 2 | $49 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $47 |
| Lilly USA, LLC | 2 | $44 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$994
- AngioJet Ultra 5000A$916
- TRICLIP$897
- Impella$680
- (9520) IGT Devices Undivided$317
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$241
- (9525) Intracardiac Und$187
- SAPIEN 3 Ultra RESILIA$168
- SYMPLICITY G3$151
- ENTRESTO$124
- Peripheral Orbital Atherectomy System$120
- Coronary Orbital Atherectomy System$120
- JETSTREAM SC$117
- AVVIGO Guidance System$114
- 3F$112
- (9148) ICE 3D$112
- (6571) Eagle Eye$108
How this compares
$13,479 in reported general payments places this provider in the 70th percentile of 170 interventional cardiology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 16 | $371 |
| Metoprolol Succinate | 17 | $88 |
| Atorvastatin Calcium | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in South Bend
- Mayank MittalSouth Bend$43K
- Khalid NajibSouth Bend$26K
- Muhammad AslamSouth Bend$14K
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Muzammil MusaniFort Wayne$184K
- Dean FerreraEast Chicago$180K
- Shashidhar DivakaruniMunster$97K
- Jarrod FrizzellEvansville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.